Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles
The synthesis and the in vitro properties of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described. Despite bearing structural similarity to rolipram, several of these compounds have much reduced affinity for the [3H]rolipram binding site.
References (26)
- et al.
Trends Pharmacol. Sci.
(1990) - et al.
Trends Pharmacol. Sci.
(1991) - et al.
Annu. Rep. Med. Chem.
(1994) - et al.
Annu. Rep. Med. Chem.
(1994) Challenges for Drug Discovery
New Drugs for Asthma-III
(July, 1994)- et al.
J. Med. Chem.
(1991) - et al.
Eur. Respir. J.
(1994) - et al.
Drugs Fut.
(1992) - et al.
Clin. Exp. Allergy
(1992)
Drug News and Perspective
(1993)
Pulm. Pharmacol.
(1994)
Biol. Pharm. Bull.
(1994)
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.